Dragoneer Investment Group LLC Has $28.86 Million Stake in Oscar Health, Inc. $OSCR

Dragoneer Investment Group LLC trimmed its stake in Oscar Health, Inc. (NYSE:OSCR) by 80.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,346,154 shares of the company’s stock after selling 5,571,294 shares during the period. Oscar Health accounts for about 0.6% of Dragoneer Investment Group LLC’s investment portfolio, making the stock its 17th largest position. Dragoneer Investment Group LLC’s holdings in Oscar Health were worth $28,862,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the period. Vanguard Group Inc. grew its stake in Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock valued at $258,247,000 after buying an additional 700,469 shares during the last quarter. Swiss National Bank raised its holdings in Oscar Health by 1.0% in the 1st quarter. Swiss National Bank now owns 328,200 shares of the company’s stock worth $4,303,000 after acquiring an additional 3,400 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Oscar Health by 19.0% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock worth $6,581,000 after acquiring an additional 79,979 shares during the period. Finally, Invesco Ltd. lifted its position in Oscar Health by 14.5% during the 1st quarter. Invesco Ltd. now owns 244,980 shares of the company’s stock worth $3,212,000 after acquiring an additional 30,954 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $121,737.42. Following the completion of the sale, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. This trade represents a 4.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 739,472 shares of company stock valued at $12,616,880 in the last ninety days. 25.11% of the stock is owned by company insiders.

Oscar Health Trading Down 0.1%

Shares of OSCR opened at $16.75 on Tuesday. The stock’s 50-day moving average price is $17.98 and its 200 day moving average price is $16.97. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $4.43 billion, a price-to-earnings ratio of -14.95 and a beta of 1.88. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter last year, the company earned ($0.22) EPS. The company’s quarterly revenue was up 23.2% on a year-over-year basis. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on OSCR. The Goldman Sachs Group began coverage on Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target on the stock. Barclays raised their target price on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th. UBS Group upped their price target on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, Oscar Health has a consensus rating of “Reduce” and a consensus target price of $14.86.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.